SCHEMBL6261971

SCHEMBL6261971

CC1(C)CCNc2nc(Br)ccc21

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RARB P10826 2/20 0.33
RARG P13631 2/20 0.33
RARA P10276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17074946 0.82 JAK2 (0.35)
SCHEMBL1815743 0.79 RARB (0.33) RARBRARGRARA
SCHEMBL16876916 0.69 RARB (0.40) RARBRARGRARA
SCHEMBL6266843 0.68 ATM (0.35)
SCHEMBL23093250 0.68 PARP10 (0.38)
SCHEMBL6266260 0.68 ITGAV (0.35)
SCHEMBL30885033 0.67 RARB (0.49) RARBRARGRARA
SCHEMBL6224511 0.67 RARB (0.49) RARBRARGRARA
SCHEMBL6266262 0.65 ITGAV (0.35)
SCHEMBL31219658 0.64 MARK3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592421-A1 HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS Pharmacia Corporation (US) 2005-11-09 EP disclosed
WO-2004058254-A1 HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA CORPORATION (US) 2004-07-15 WO disclosed
WO-2004058254-A1 HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA CORPORATION (US) 2004-07-15 WO disclosed